redcare pharmacy nv - SHPPF

SHPPF

Close Chg Chg %
48.75 -3.57 -7.31%

Pre-Market

45.18

-3.57 (7.31%)

Volume: 55.00

Last Updated:

Mar 16, 2026, 12:28 PM EDT

Company Overview: redcare pharmacy nv - SHPPF

SHPPF Key Data

Open

$45.18

Day Range

45.18 - 45.18

52 Week Range

45.18 - 148.22

Market Cap

$867.61M

Shares Outstanding

20.11M

Public Float

15.09M

Beta

1.60

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.13

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

SHPPF Performance

No Data Available

SHPPF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About redcare pharmacy nv - SHPPF

Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.

SHPPF At a Glance

Redcare Pharmacy NV
Erik de Rodeweg 11/13
Sevenum, Limburg 5975 WD
Phone N/A Revenue 3.32B
Industry Medical Distributors Net Income -42,547,388.74
Sector Distribution Services 2025 Sales Growth 29.436%
Fiscal Year-end 12 / 2026 Employees 2,649
View SEC Filings

SHPPF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.463
Price to Book Ratio 2.851
Price to Cash Flow Ratio 59.23
Enterprise Value to EBITDA 35.172
Enterprise Value to Sales 0.545
Total Debt to Enterprise Value 0.27

SHPPF Efficiency

Revenue/Employee 1,252,938.805
Income Per Employee -16,061.679
Receivables Turnover 18.495
Total Asset Turnover 2.626

SHPPF Liquidity

Current Ratio 1.549
Quick Ratio 1.014
Cash Ratio 0.509

SHPPF Profitability

Gross Margin 20.188
Operating Margin -0.809
Pretax Margin -1.636
Net Margin -1.282
Return on Assets -3.366
Return on Equity -8.445
Return on Total Capital -4.141
Return on Invested Capital -5.088

SHPPF Capital Structure

Total Debt to Total Equity 90.505
Total Debt to Total Capital 47.508
Total Debt to Total Assets 33.341
Long-Term Debt to Equity 71.712
Long-Term Debt to Total Capital 37.643
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Redcare Pharmacy Nv - SHPPF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.27B 1.94B 2.56B 3.32B
Sales Growth
+0.99% +53.64% +31.86% +29.44%
Cost of Goods Sold (COGS) incl D&A
958.57M 1.53B 2.05B 2.65B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
41.53M 61.93M 73.79M 78.32M
Depreciation
14.54M 17.33M 19.55M 20.99M
Amortization of Intangibles
26.99M 44.60M 54.24M 57.33M
COGS Growth
-1.19% +59.66% +33.79% +29.37%
Gross Income
307.17M 414.17M 516.57M 670.04M
Gross Income Growth
+8.46% +34.83% +24.73% +29.71%
Gross Profit Margin
+24.27% +21.30% +20.15% +20.19%
2022 2023 2024 2025 5-year trend
SG&A Expense
364.83M 432.27M 559.12M 695.43M
Research & Development
- - - -
-
Other SG&A
364.83M 432.27M 559.12M 695.43M
SGA Growth
+9.06% +18.48% +29.35% +24.38%
Other Operating Expense
- - - 1.47M
-
Unusual Expense
- 16.71M (12.95M) (338.57K)
EBIT after Unusual Expense
(74.37M) (5.15M) (42.55M) (26.52M)
Non Operating Income/Expense
641.09K 6.11M (928.09K) (4.85M)
Non-Operating Interest Income
- - - 4.97M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
15.03M 16.72M 8.72M 22.91M
Interest Expense Growth
-3.06% +11.20% -47.86% +162.84%
Gross Interest Expense
15.03M 16.72M 8.72M 22.91M
Interest Capitalized
- - - -
-
Pretax Income
(88.76M) (15.76M) (52.19M) (54.28M)
Pretax Income Growth
+3.05% +82.25% -231.23% -4.01%
Pretax Margin
-7.01% -0.81% -2.04% -1.64%
Income Tax
(6.80M) (2.96M) (1.60M) (9.37M)
Income Tax - Current - Domestic
(55.70K) 1.06M 699.85K 1.02M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(6.75M) (4.02M) (2.30M) (10.38M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(81.60M) (12.55M) (50.14M) (44.47M)
Minority Interest Expense
- 470.29K (964.87K) (1.92M)
Net Income
(81.60M) (13.02M) (49.18M) (42.55M)
Net Income Growth
+6.94% +84.05% -277.78% +13.48%
Net Margin Growth
-6.45% -0.67% -1.92% -1.28%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(81.60M) (13.02M) (49.18M) (42.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(81.60M) (13.02M) (49.18M) (42.55M)
EPS (Basic)
-4.5374 -0.6766 -2.4523 -2.1158
EPS (Basic) Growth
+7.46% +85.09% -262.44% +13.72%
Basic Shares Outstanding
17.98M 19.24M 20.05M 20.11M
EPS (Diluted)
-4.5374 -0.6766 -2.4523 -2.1158
EPS (Diluted) Growth
+7.46% +85.09% -262.44% +13.72%
Diluted Shares Outstanding
17.98M 19.24M 20.05M 20.11M
EBITDA
(16.13M) 43.84M 31.24M 51.46M
EBITDA Growth
+17.21% +371.73% -28.73% +64.71%
EBITDA Margin
-1.27% +2.25% +1.22% +1.55%

Redcare Pharmacy Nv in the News